Young withdrawn man talking to a professional

NIHR psychosis therapy trial shows potential life-changing benefits

Half of patients with psychosis on a new therapy programme demonstrated significant benefits, according to the results of an NIHR-funded clinical trial.

The newly-published study findings demonstrated potentially life-changing benefits for patients from the new Feeling Safe programme, which is designed to support those with psychosis to return to everyday activities.

In total, 50% of patients in the study achieved significant benefits from the Feeling Safe programme, with a further 25% making moderate gains.

As a result, the Feeling Safe programme has been highlighted as the most effective psychological treatment for persecutory delusions (unfounded, strong beliefs that other people intend to harm you).

The therapy is delivered across 20 sessions, with patients fully involved with decisions about their treatment.

In particular, the treatment is based on the belief that people facing persecutory delusions can make gains by trying out everyday things, with the therapy helping patients to develop new memories of safety and address factors that often maintain persecutory thoughts, such as worry, poor sleep and low self-confidence.

The clinical trial was led by NIHR Research Professor Daniel Freeman, Department of Psychiatry at the University of Oxford, with his research team being supported by the NIHR Oxford Health Biomedical Research Centre.

Within the trial, researchers conducted a randomised controlled trial with 130 patients for whom delusions persisted despite standard treatments.

Professor Freeman said: “Feeling Safe is the result of more than ten years of research and clinical practice, built on listening carefully to patients to really understand the causes of the problems they face.

“The trial results give us great cause for optimism in the treatment of a problem that is very common in people with psychosis, immensely distressing for patients and families, and yet often does not improve sufficiently with current treatments.”

It is hoped the new treatment can make substantial differences to the quality of life for people with psychosis, particularly persecutory delusions, which can often have deep impacts to a person’s health and wellbeing.

Four out of five people affected are unemployed and withdrawn from social and leisure activities, with life expectancy on average 14.5 years shorter, due to largely preventable health conditions exacerbated by inactivity.

Dr Felicity Waite, Clinical Psychologist in the Department of Psychiatry at the University of Oxford, added: “So many of the patients we visited were spending virtually all their time at home.

“Our aim was to bring them back into everyday life, to help them get back to the things they like doing. The positive change Feeling Safe brought about is wonderful to see.”

NHE September/October 2023

NHE September/October 2023

Empowering the next generation to lead the way in hard-to-treat cancers.

The September/October 2023 edition of NHE brings you expert comment and analysis on a range of key health sector topics, from digital transformation to navigating post-pandemic challenges.


View all videos
National Health Executive Presents

National Health Executive Presents

NHE365 Virtual Events

NHE has created a full calendar of events to address the most important issues that influence the delivery of healthcare services. Over 365 days you'll have the opportunity to hear from a range of highly motivating, informative and inspirational speakers. These speakers will equip you with the knowledge and unique insight to enable you to overcome the challenges that you face.

National Health Executive Podcast

Ep. 36
How interoperability can support the NHS's core goals
with Ed Platt

In episode 36 of the National Health Executive podcast, we were joined by Omnicell’s UK professional services director, Ed Platt, to discuss interoperability in the NHS, practical examples of where it can be leveraged best, the importance of the health service's digital transformation journey and more.

More articles...

View all